ranolazine has been researched along with Cardiomegaly in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alsina, KM; Chen, C; Duan, Q; He, M; Li, X; Ni, L; Nie, J; Wang, B; Wang, DW; Wehrens, XHT; Wen, Z; Wu, L; Zhou, C | 1 |
| Belardinelli, L; Danner, BC; Fischer, TH; Hartmann, N; Hasenfuss, G; Herting, J; Hund, TJ; Maier, LS; Mohler, PJ; Sag, CM; Sossalla, S; Toischer, K; Wagner, S | 1 |
| Glynn, P; Gyorke, S; Hund, TJ; Little, S; Mohler, PJ; Musa, H; Qian, L; Radwanski, PB; Unudurthi, SD; Wright, PJ; Wu, X | 1 |
| Eckardt, L; Vogler, J | 1 |
1 review(s) available for ranolazine and Cardiomegaly
| Article | Year |
|---|---|
Pharmacology of myocardial calcium-handling.
Topics: Acetanilides; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Calcium; Calcium Channel Blockers; Cardiomegaly; Cardiotonic Agents; Digitalis Glycosides; Dronedarone; Electrocardiography; Heart Failure; Humans; Ion Channels; Myocardial Contraction; Piperazines; Ranolazine; Signal Transduction; Tachycardia | 2012 |
3 other study(ies) available for ranolazine and Cardiomegaly
| Article | Year |
|---|---|
Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na
Topics: Animals; Calcium; Cardiomegaly; Cardiovascular Agents; Cell Line; Fibrosis; Heart Failure; Hypertension; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Random Allocation; Ranolazine; Sodium | 2019 |
Role of late sodium current as a potential arrhythmogenic mechanism in the progression of pressure-induced heart disease.
Topics: Acetanilides; Action Potentials; Animals; Arrhythmias, Cardiac; Blood Pressure; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cells, Cultured; Female; Heart Failure; Heart Ventricles; Mice; Mice, Inbred C57BL; NAV1.1 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Peptides; Piperazines; Ranolazine; Sodium; Sodium Channel Blockers; Tetrodotoxin | 2013 |
Voltage-Gated Sodium Channel Phosphorylation at Ser571 Regulates Late Current, Arrhythmia, and Cardiac Function In Vivo.
Topics: Acetanilides; Action Potentials; Animals; Arrhythmias, Cardiac; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Constriction; Gene Knock-In Techniques; Ion Channel Gating; Male; Mice; Mice, Inbred C57BL; NAV1.5 Voltage-Gated Sodium Channel; Phosphorylation; Phosphoserine; Piperazines; Protein Processing, Post-Translational; Ranolazine; Sodium; Sodium Channel Blockers; Ventricular Remodeling | 2015 |